Cytek Biosciences Inc (CTKB)
Return on assets (ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -6,019 | -10,159 | -17,556 | -11,510 | -12,148 | -14,122 | -6,000 | -2,210 | 2,439 | -865 | -936 | 2,332 | 4,592 | 9,966 | 14,911 | 20,352 | 19,411 |
| Total assets | US$ in thousands | 499,500 | 491,226 | 483,725 | 492,067 | 497,669 | 519,430 | 525,054 | 524,575 | 519,476 | 499,295 | 492,817 | 485,879 | 463,700 | 454,320 | 230,279 | 224,264 | 219,979 |
| ROA | -1.21% | -2.07% | -3.63% | -2.34% | -2.44% | -2.72% | -1.14% | -0.42% | 0.47% | -0.17% | -0.19% | 0.48% | 0.99% | 2.19% | 6.48% | 9.08% | 8.82% |
December 31, 2024 calculation
ROA = Net income (ttm) ÷ Total assets
= $-6,019K ÷ $499,500K
= -1.21%
Cytek Biosciences Inc's return on assets (ROA) has experienced a significant decline over the period from December 31, 2020, to December 31, 2024.
The ROA started at a relatively healthy 8.82% at the end of December 2020 and experienced a slight increase to 9.08% by the end of March 2021. However, starting from June 2021, the ROA began a downward trend, dropping to 6.48% by June 2021, and further declining to 0.99% by the end of December 2021.
The decline in ROA continued into the following years, with negative values recorded from March 2022 to December 2024, indicating that Cytek Biosciences Inc's assets were not effectively generating profits during these periods.
The negative ROA values suggest that Cytek Biosciences Inc may be facing challenges in efficiently utilizing its assets to generate profits or that the company may have incurred significant losses relative to its asset base.
Overall, the declining trend in ROA raises concerns about Cytek Biosciences Inc's profitability and asset management efficiency over the analyzed period, signifying a need for further investigation and potentially strategic changes to improve the company's financial performance.
Peer comparison
Dec 31, 2024